tiprankstipranks
Trending News
More News >
Avenue Therapeutics Inc (ATXI)
OTHER OTC:ATXI
US Market

Avenue Therapeutics (ATXI) Income Statement

Compare
331 Followers

Avenue Therapeutics Income Statement

Last quarter (Q1 2025), Avenue Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q1, Avenue Therapeutics's net income was $-1.85M. See Avenue Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 11.28M$ 14.54M$ 8.04M$ 3.74M$ 5.21M
Depreciation and Amortization
$ 0.00$ 14.54M$ 8.04M$ 3.74M$ 5.21M
EBITDA
$ -11.28M$ 4.05M$ -8.02M$ -3.73M$ -5.21M
Operating Income
$ -11.28M$ -14.54M$ -8.04M$ -3.74M$ -5.21M
Other Income/Expenses
$ -369.00K$ 4.05M$ 4.44M$ 7.00K$ 62.00K
Pretax Income
$ -11.65M$ -10.49M$ -3.60M$ -3.73M$ -5.15M
Net Income
$ -11.65M$ -10.38M$ -3.55M$ -3.73M$ -5.15M
Per Share Metrics
Basic EPS
$ -0.90$ -73.60$ -1.63$ -3.29$ -4.65
Diluted EPS
$ -0.90$ -73.48$ -1.63$ -3.29$ -4.65
Weighted Average Shares Outstanding
12.95M 141.00K 29.14K 1.13M 1.10M
Weighted Average Shares Outstanding (Diluted)
12.95M 141.22K 29.14K 1.13M 1.10M
Currency in USD

Avenue Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis